je.st
news
Tag: compugen
Compugen Presents Results For CGEN-15029 Immuno-Oncology Program
2016-03-01 01:32:56| drugdiscoveryonline News Articles
In an oral presentation today at the New York Academy of Sciences' Emerging Approaches to Cancer Immunotherapy conference, John Hunter, Ph.D., Site Head and Vice President of Antibody R&D at Compugen USA, Inc., a wholly owned subsidiary of Compugen Ltd. (NASDAQ: CGEN), presented results for CGEN-15029, the lead internal program in the Company's immuno-oncology therapeutics pipeline.
Tags: results
program
presents
presents results
Compugen Expands and Strengthens Busines ...
2015-02-23 23:17:18| Biotech - Topix.net
Compugen Ltd. today announced the appointment of Dr. Felix Karim as Vice President Corporate & Business Development, effective March 2, 2015. Dr. Karim, who will be based at Compugen's South San Francisco facilities, will report to Dr. Anat Cohen-Dayag, Compugen's President and Chief Executive Officer, and will have direct responsibility for the Company's business development strategy and its execution.
Tags: expands
strengthens
busines
compugen
Compugen Discloses New Results For Novel Target Candidate For Cancer Immunotherapy
2014-10-01 14:07:35| drugdiscoveryonline Home Page
Compugen Ltd. recently disclosed results from recent studies further confirming CGEN-15049 as a promising target candidate for cancer immunotherapy. These recent studies evaluated the function of this Compugen-discovered immune checkpoint candidate on immune cells derived from the tumor environment of melanoma patients
Tags: results
target
cancer
candidate
Compugen Extends Discovery Capabilities To Additional Immunomodulatory Proteins
2014-07-30 10:01:01| drugdiscoveryonline Home Page
Compugen Ltd. recently announced the extension of its predictive discovery capability to identify immunomodulatory proteins in addition to the B7/CD28-like proteins that have been the focus of the Company’s Pipeline Program to date. The initial utilization of this extended capability resulted in the discovery of four novel immunomodulatory proteins predicted to act as immune checkpoints
Tags: additional
discovery
capabilities
proteins
Compugen to Present Predictive Methodology for Discovery of Novel...
2014-01-23 00:39:21| Biotech - Topix.net
Ltd. today announced that Dr. John Hunter of Compugen USA, Inc. will present at the Washington BioLeaders Forum 2014 to be held next week in Washington, D.C. In his talk, which is scheduled for January 28 in the Phacilitate Immunotherapy Forum track, Dr. Hunter will demonstrate how Compugen has applied its predictive discovery platforms to identify ... (more)
Tags: present
novel
discovery
methodology